Vimarsana
Biggest News Aggregation in the World

Page 11 - Linical Evolution News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Linical Evolution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Linical Evolution Today - Breaking & Trending Today

FDA approval expands Welireg to patients with renal cell carcinoma - Vimarsana News

FDA approval expands Welireg to patients with renal cell carcinoma

The oral treatment belzutifan, developed by MSD (known as Merck in the US) and branded as Welireg, has received the green light from the US Food and Drug Administration (FDA) for the treatment of an advanced form of renal cell carcinoma (RCC).

UK approves treatment for hot flushes during the menopause - Vimarsana News

UK approves treatment for hot flushes during the menopause

Astellas’ drug fezolinetant (Veoza) has been approved by the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for the prevention of hot flashes during the menopause.

Mission Therapeutics moves kidney disease drug to phase 2 after FDA approval - Vimarsana News

Mission Therapeutics moves kidney disease drug to phase 2 after FDA approval

Mission Therapeutics, a clinical-stage biotech developing first-in-class therapeutics targeting mitophagy, has received Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA) to proceed with a phase 2 trial for its kidney treatment MTX652.

HIV pathology data now reaching investigators within hours - Vimarsana News

HIV pathology data now reaching investigators within hours

The AIDS and Cancer Specimen (ACSR), a biorepository of specimens collected from persons living with HIV (PLWH) has today (December 12) announced it is using software from Proscia that can provide near real-time access to pathology data to investigators around the world.

Pharma-grade cannabis contracts secured by Celadon - Vimarsana News

Pharma-grade cannabis contracts secured by Celadon

Celadon Pharmaceuticals has today (December 14) announced its first supply of it pharmaceutical-grade breakthrough cannabis-based medicine.